VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 59 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,882,238 | -41.2% | 663,610 | -32.5% | 3.29% | -35.1% |
| Q4 2022 | $28,731,248 | +20.3% | 983,610 | -15.5% | 5.07% | -29.2% |
| Q3 2022 | $23,874,000 | +57.0% | 1,164,000 | -11.4% | 7.16% | +10.9% |
| Q2 2022 | $15,203,000 | -37.4% | 1,314,000 | 0.0% | 6.46% | -33.8% |
| Q1 2022 | $24,296,000 | -6.5% | 1,314,000 | 0.0% | 9.75% | -19.8% |
| Q4 2021 | $25,978,000 | – | 1,314,000 | – | 12.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |